Tizanidine Does Not Cause Atrial Fibrillation
Tizanidine is not associated with atrial fibrillation based on FDA labeling and available evidence. The drug's primary cardiac adverse effects are hypotension and bradycardia, not atrial arrhythmias.
Primary Cardiac Effects of Tizanidine
The FDA label for tizanidine clearly identifies its cardiovascular risks 1:
- Hypotension: Two-thirds of patients on 8 mg experience 20% reduction in blood pressure, peaking 2-3 hours post-dose
- Bradycardia: Documented as occurring with hypotension
- Orthostatic hypotension and syncope: Rare but documented
Notably absent from the FDA warnings and adverse events sections is any mention of atrial fibrillation or atrial arrhythmias.
Case Report Evidence Shows Bradycardia, Not Atrial Fibrillation
One case report describes a 93-year-old woman who developed profound bradycardia after a single 4 mg dose of tizanidine 2. The electrocardiogram showed atrial fibrillation with slow ventricular response (heart rate 19 bpm). This is critical to understand: the patient had pre-existing atrial fibrillation that became symptomatic due to tizanidine-induced bradycardia—tizanidine did not cause the atrial fibrillation itself.
Another case involved a 37-year-old man who developed irreversible bradycardia requiring a pacemaker after tizanidine/loxoprofen combination therapy 3. Again, bradycardia was the adverse effect, not atrial fibrillation.
Mechanism of Action Supports Bradycardia, Not Atrial Fibrillation
Tizanidine is an α2-adrenergic agonist (similar to clonidine) 1. This mechanism:
- Reduces sympathetic outflow
- Causes hypotension and bradycardia
- Does not activate potassium channels or alter atrial action potential duration—mechanisms that would predispose to atrial fibrillation
This contrasts sharply with drugs that actually cause atrial fibrillation through mechanisms like atrial remodeling, inflammation, or ion channel effects 4.
Drug-Induced Atrial Fibrillation Literature Does Not Implicate Tizanidine
The comprehensive 2024 guideline on drug-induced atrial fibrillation from Pharmacological Research 4 reviews numerous medications that cause atrial fibrillation, including:
- Anticancer drugs (tyrosine kinase inhibitors, anthracyclines)
- Cardiovascular drugs (dobutamine, milrinone)
- Theophylline
- Bisphosphonates
Tizanidine is not mentioned anywhere in this extensive review, despite the guideline's comprehensive approach to identifying drugs associated with atrial fibrillation.
Clinical Bottom Line
If a patient on tizanidine develops atrial fibrillation, look for other causes. The atrial fibrillation is likely:
- Pre-existing and unmasked by bradycardia
- Related to underlying cardiovascular disease
- Caused by other medications
- Due to other AF risk factors (age, hypertension, structural heart disease)
The primary cardiac concern with tizanidine is symptomatic bradycardia and hypotension, particularly in:
- Elderly patients (clearance decreased 4-fold) 1
- Patients on concurrent antihypertensives 1
- Women taking oral contraceptives (50% reduction in clearance) 1
- Patients with renal insufficiency (>50% reduction in clearance) 1
Monitor heart rate and blood pressure when initiating tizanidine, especially in high-risk populations, but atrial fibrillation is not an expected adverse effect of this medication.